These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7793236)

  • 1. Lamotrigine as an add-on drug in typical absence seizures.
    Ferrie CD; Robinson RO; Knott C; Panayiotopoulos CP
    Acta Neurol Scand; 1995 Mar; 91(3):200-2. PubMed ID: 7793236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine in absence and primary generalized epilepsies.
    Mikati MA; Holmes GL
    J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
    Marson AG; Al-Kharusi AM; Alwaidh M; Appleton R; Baker GA; Chadwick DW; Cramp C; Cockerell OC; Cooper PN; Doughty J; Eaton B; Gamble C; Goulding PJ; Howell SJ; Hughes A; Jackson M; Jacoby A; Kellett M; Lawson GR; Leach JP; Nicolaides P; Roberts R; Shackley P; Shen J; Smith DF; Smith PE; Smith CT; Vanoli A; Williamson PR;
    Lancet; 2007 Mar; 369(9566):1016-26. PubMed ID: 17382828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
    Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
    Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A; Goa KL
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine for the treatment of epilepsy in childhood.
    Besag FM; Wallace SJ; Dulac O; Alving J; Spencer SC; Hosking G
    J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of lamotrigine and valproate in refractory epilepsies of children and adolescents.
    Grisotto KP; Bruck I; Antoniuk SA; Santos LH
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):477-81. PubMed ID: 18813703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of lamotrigine in idiopathic generalized epilepsy syndromes: a video-EEG-controlled, open study.
    Gericke CA; Picard F; de Saint-Martin A; Strumia S; Marescaux C; Hirsch E
    Epileptic Disord; 1999 Sep; 1(3):159-65. PubMed ID: 10937148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ; Rahey SR; Sadler RM
    Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic interaction of lamotrigine and sodium valproate in intractable myoclonic epilepsy.
    Ferrie CD; Panayiotopoulos CP
    Seizure; 1994 Jun; 3(2):157-9. PubMed ID: 8081644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of lamotrigine in the treatment of absence epilepsy crises].
    Mauri-Llerda JA; Tejero-Juste C; Iñiguez C; Morales-Asín F
    Rev Neurol; 2001 Feb 1-15; 32(3):247-50. PubMed ID: 11310280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.
    Coppola G; Pascotto A
    Brain Dev; 1997 Sep; 19(6):398-402. PubMed ID: 9339867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Posner EB; Mohamed K; Marson AG
    Cochrane Database Syst Rev; 2003; (3):CD003032. PubMed ID: 12917940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of refractory idiopathic epilepsies.
    Perucca E
    Epilepsia; 2001; 42 Suppl 3():31-5. PubMed ID: 11520320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine in typical absence epilepsy.
    Buoni S; Grosso S; Fois A
    Brain Dev; 1999 Jul; 21(5):303-6. PubMed ID: 10413016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lamotrigine (Lamictal)].
    Scheen AJ
    Rev Med Liege; 1997 Nov; 52(11):738-40. PubMed ID: 9480501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.